Anti-Xa monitoring: Inter-assay variability

Thrombosis and Haemostasis

Volumn 84, Issue 6, 2000, Pages 1122-1123

  Depasse, F ^a   Gilbert, M ^a   Goret, V ^a   Rolland, N ^a   Samama, M M ^a  

^a Laboratoire LCL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10A; COATEST; DALTEPARIN; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; REVIPARIN; ROTACHROM; STA; STACHROM; TINZAPARIN;

ANALYTIC METHOD; ANTICOAGULATION; ASSAY; BLOOD CLOTTING; HEMOSTASIS; HUMAN; INTERMETHOD COMPARISON; LETTER; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN ANALYSIS; THROMBOSIS;

EID: 0034537905     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614183     Document Type: Letter

References (4)

1. Anti-Xa monitoring during treatment with low molecular weight heparin or danaparoid: Inter-assay variability
2. Measurement of low molecular weight heparin ex vivo activities in clinical laboratories using various anti-Xa assays: Interlaboratory variability and requirement for an agreed low molecular weight heparin standard
3. Monitoring therapy with LMW heparin: A comparison of three chromogenic substrate assays and the Heptest clotting assay
4. Validation protocol of analytical hemostasis systems: Measurement of anti-Xa activity of low-molecular-weight heparins